Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wacker Chemie operates globally as a specialty chemicals company with significant activities in life sciences through its BIOSOLUTIONS division. Its subsidiary Wacker Biotech acts as a full-service microbial CDMO specializing in the GMP manufacture of plasmid DNA, mRNA/LNPs, therapeutic proteins, live biotherapeutic products and vaccines. The company does not develop proprietary therapeutics but enables clinical and commercial supply of advanced therapies for clients worldwide. It has expanded capacity recently to meet growing demand in gene/cell therapy manufacturing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wacker Chemie.